Calcium-dependent vasorelaxant capacity of levosimendan in porcine and human epicardial coronary artery preparations.
Krassói
I
I
Pataricza
J
J
Kun
A
A
Papp
J G
JG
D000293:Adolescent; D000328:Adult; D000818:Animals; D002118:Calcium / Q000502:physiology*; D003331:Coronary Vessels / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010496:Pericardium / Q000502:physiology; D011724:Pyridazines / Q000494:pharmacology*; D000077464:Simendan; D013552:Swine; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan; D002118:Calcium